Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...
Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...
The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for ...
Qure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.
Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...
“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead ...
BIOSPAIN 2025 returns to Barcelona, bringing 2,200+ biotech professionals for networking, collaborations, and industry ...
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene-editing technology that allows scientists to modify DNA with unprecedented precision. Discovered in the early 2010s, CRISPR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback